MedPath

Spectral Analysis of Central Venous Pressure Waveform

Completed
Conditions
Donor Hepatectomy
Central Venous Catheter
Hypovolemia
Interventions
Procedure: Placement of a central venous catheter
Device: Monitoring of central venous pressure
Drug: Furosemide-induced hypovolemia before graft procurement
Drug: Replacement of fluid loss after graft procurement
Device: Monitoring of stroke volume variation
Registration Number
NCT04733547
Lead Sponsor
JongHae Kim
Brief Summary

The use of central venous pressure has been abandoned for the assessment of intravascular volume status. The dynamic fluctuation of central venous pressure according to heart rate is quantitatively measured by spectral analysis of the central venous pressure waveform. Its clinical utility in the assessment of intravascular volume status is investigated.

Detailed Description

The use of central venous pressure, which is one of the static preload indices, has been abandoned for the assessment of intravascular volume status because of its unreliability. The static preload indices have been replaced with dynamic preload indices, such as stroke volume variation or pulse pressure variation because the dynamic preload indices reliably predict fluid responsiveness and perform better than the static preload indices. However, the periodic component of central venous pressure, which goes with cardiac cycles, has not been investigated. The power corresponding to heart rate from spectral analysis of central venous pressure waveform represents the extent of the dynamic fluctuation of central venous pressure and is assumed to reflect intravascular volume status. It is hypothesized that the spectral power of central venous pressure corresponding to heart rate represents intravascular volume status.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • American Society of Anesthesiologists physical status 1
  • Scheduled for donor hepatectomy under general anesthesia
Exclusion Criteria
  • Arrhythmia
  • Valvular heart disease
  • Coronary artery disease
  • Cerebrovascular disease
  • Hypertension
  • Diabetes mellitus
  • Renal insufficiency
  • Pulmonary problems
  • Any type of liver disease
  • Body mass index greater than 35 kg/m2
  • Human immunodeficiency virus infection
  • Psychosocial problems
  • Electrolyte imbalance
  • Reoperation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Donor hepatectomyReplacement of fluid loss after graft procurementLive donors undergoing hepatectomy
Donor hepatectomyPlacement of a central venous catheterLive donors undergoing hepatectomy
Donor hepatectomyMonitoring of central venous pressureLive donors undergoing hepatectomy
Donor hepatectomyFurosemide-induced hypovolemia before graft procurementLive donors undergoing hepatectomy
Donor hepatectomyMonitoring of stroke volume variationLive donors undergoing hepatectomy
Primary Outcome Measures
NameTimeMethod
Spectral power of central venous pressure corresponding to heart rate during 5 minutes before graft procurementDuring 5 minutes before graft procurement

A band-pass filter (0.15-3 Hz) is applied to the 5 minute-long segment. The 5 minute-long segments are divided into 100 second-long segments overlapping 50% with each adjacent segment. Each segment is submitted to fast Fourier transformation. The spectral powers obtained from the periodograms of each segment are averaged. The integrated area corresponding to heart rate is the spectral power corresponding to heart rate.

Secondary Outcome Measures
NameTimeMethod
Spectral powers of central venous pressure corresponding to respiratory rate and heart rate during 5 minutes before the first dose of furosemideDuring 5 minutes before the first dose of furosemide

A band-pass filter (0.15-3 Hz) is applied to the 5 minute-long segment. The 5 minute-long segments are divided into 100 second-long segments overlapping 50% with each adjacent segment. Each segment is submitted to fast Fourier transformation. The spectral powers obtained from the periodograms of each segment are averaged. The integrated areas corresponding to respiratory rate and heart rate are the spectral powers corresponding to respiratory rate and heart rate.

Spectral powers of central venous pressure corresponding to respiratory rate and heart rate between 30 and 35 minutes after surgical incisionBetween 30 and 35 minutes after surgical incision

A band-pass filter (0.15-3 Hz) is applied to the 5 minute-long segment. The 5 minute-long segments are divided into 100 second-long segments overlapping 50% with each adjacent segment. Each segment is submitted to fast Fourier transformation. The spectral powers obtained from the periodograms of each segment are averaged. The integrated areas corresponding to respiratory rate and heart rate are the spectral powers corresponding to respiratory rate and heart rate.

Spectral power of central venous pressure corresponding to respiratory rate during 5 minutes before graft procurementDuring 5 minutes before graft procurement

A band-pass filter (0.15-3 Hz) is applied to the 5 minute-long segment. The 5 minute-long segments are divided into 100 second-long segments overlapping 50% with each adjacent segment. Each segment is submitted to fast Fourier transformation. The spectral powers obtained from the periodograms of each segment are averaged. The integrated area corresponding to respiratory rate is the spectral power corresponding to respiratory rate.

Spectral powers of central venous pressure corresponding to respiratory rate and heart rate during 5 minutes after administration of 6% hydroxyethyl starchDuring 5 minutes after administration of 6% hydroxyethyl starch

A band-pass filter (0.15-3 Hz) is applied to the 5 minute-long segment. The 5 minute-long segments are divided into 100 second-long segments overlapping 50% with each adjacent segment. Each segment is submitted to fast Fourier transformation. The spectral powers obtained from the periodograms of each segment are averaged. The integrated areas corresponding to respiratory rate and heart rate are the spectral powers corresponding to respiratory rate and heart rate.

Stroke volume variation during 5 minutes before the first dose of furosemideDuring 5 minutes before the first dose of furosemide

The median of the values calculated at a 20-second interval

Stroke volume index during 5 minutes before the first dose of furosemideDuring 5 minutes before the first dose of furosemide

The median of the values calculated at a 20-second interval

Cardiac index during 5 minutes before the first dose of furosemideDuring 5 minutes before the first dose of furosemide

The median of the values calculated at a 20-second interval

Stroke volume variation between 30 and 35 minutes after surgical incisionBetween 30 and 35 minutes after surgical incision

The median of the values calculated at a 20-second interval

Stroke volume index between 30 and 35 minutes after surgical incisionBetween 30 and 35 minutes after surgical incision

The median of the values calculated at a 20-second interval

Cardiac index between 30 and 35 minutes after surgical incisionBetween 30 and 35 minutes after surgical incision

The median of the values calculated at a 20-second interval

Stroke volume variation during 5 minutes before graft procurementDuring 5 minutes before graft procurement

The median of the values calculated at a 20-second interval

Stroke volume index during 5 minutes before graft procurementDuring 5 minutes before graft procurement

The median of the values calculated at a 20-second interval

Cardiac index during 5 minutes before graft procurementDuring 5 minutes before graft procurement

The median of the values calculated at a 20-second interval

Stroke volume variation during 5 minutes after administration of 6% hydroxyethyl starchDuring 5 minutes after administration of 6% hydroxyethyl starch

The median of the values calculated at a 20-second interval

Stroke volume index during 5 minutes after administration of 6% hydroxyethyl starchDuring 5 minutes after administration of 6% hydroxyethyl starch

The median of the values calculated at a 20-second interval

Cardiac index during 5 minutes after administration of 6% hydroxyethyl starchDuring 5 minutes after administration of 6% hydroxyethyl starch

The median of the values calculated at a 20-second interval

Total dose of furosemideAt graft procurement

The total dose of furosemide used for the promotion of diuresis

Urine output at graft procurementAt graft procurement

The total amount of urine output between the placement of urinary catheter and graft procurement

Total urine output at the end of surgeryAt the end of surgery

The total amount of urine output at the end of surgery

Intraoperative blood loss1 day after surgery

Calculated as blood loss (ml) = \[estimated blood volume\*(preoperative hematocrit-postoperative hematocrit)\]/mean between the 2 hematocrit values, where estimated blood volume (ml) = weight(kg)\^0.425\*height(cm)\^0.725\*0.007184\*2217+age(years)\*1.06 for female and weight(kg)\^0.425\*height(cm)\^0.725\*0.007184\*3064-825 for male

Trial Locations

Locations (1)

Daegu Catholic University Medical Center

🇰🇷

Daegu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath